Solgenics Limited Notice of GM (8625Y)
May 10 2023 - 2:00AM
UK Regulatory
TIDMSGN
RNS Number : 8625Y
Solgenics Limited
10 May 2023
News Release
Notice of General Meeting
10 May 2023: Solgenics Limited ("Solgenics" or the "Company")
(AIM:SGN), the African power development company focused on
renewable energy solutions, announces that, further to the
announcement on 3 May 2023, it will today publish and post a
Shareholder circular (the "Circular") containing, amongst other
things, further details of the proposed cancellation of the
Company's ordinary shares from admission to trading on AIM and the
associated resolutions to be proposed at a general meeting of the
Company (the "General Meeting"). The General Meeting will be held
at the offices of Simmons & Simmons LLP at CityPoint, One
Ropemaker Street, London, EC2Y 9SS at 10.00 a.m. on 26 May
2023.
At the General Meeting, the Company is seeking shareholder
approval to cancel the admission of Ordinary Shares to trading on
AIM and if the cancellation is approved to amend the Company's
Articles of Association.
A copy of a shareholder circular will shortly be available for
viewing on the Company's website at
http://www.solgenics.com/investors .
Enquiries
For further information please visit www.solgenics.com or
contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566
Liberum Capital Limited: Scott Mathieson, Edward Thomas, +44 (0) 20 3100
NOMAD & Joint Broker Kane Collings 2000
Novum Securities
Limited +44 (0) 20 7399
Joint Broker Colin Rowbury 9427
Pimlico Advisory
Ltd +44 (0) 777 56 55
Investor Relations Elizabeth Johnson 927
About Solgenics
Solgenics is an African renewable energy development company
focused on the development of a 300MW solar PV plus BESS renewable
energy in the Tete Province in northern Mozambique (the "Tete Solar
Project").
It is the intention that the Tete Solar Project will connect to
the Mozambique grid with target power offtakers in Mozambique and
the Southern African Power Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's
leading sustainable energy resources and is fully aligned with
Government's objective to become a champion for energy transition
impacting all Southern Africa.
On 3 May 2023, Solgenics announced that it will shortly be
posting a circular to shareholders (in connection with a proposal
for the cancellation of admission of the ordinary shares of no par
value in the Company ("Ordinary Shares") to trading on AIM (the
"Cancellation"), pursuant to Rule 41 of the AIM Rules for
Companies. Accordingly, if the resolution to approve the
cancellation is approved by shareholders, the last day of dealings
in the Ordinary Shares on AIM is expected to be 6 June 2023, and
the Cancellation is expected to become effective at 7.00 a.m. on 7
June 2023.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOGEAESNEDSDEAA
(END) Dow Jones Newswires
May 10, 2023 02:00 ET (06:00 GMT)
Solgenics (LSE:SGN)
Historical Stock Chart
From Oct 2024 to Nov 2024
Solgenics (LSE:SGN)
Historical Stock Chart
From Nov 2023 to Nov 2024